48
Participants
Start Date
July 1, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Carbon ion radiotherapy
Patients with locally advanced unresectable pancreatic cancer without invasion of gastrointestinal tract will received ablative carbon ion radiotherapy. The prescription dose for primary pancreatic lesion, positive lymph node, and retroperitoneal high-risk recurrence area is 67.5 Gy (RBE weighted dose) in 15 fractions for 3 weeks; Pancreatic primary lesion and positive lymph node SIB to 75 Gy (RBE weighted dose) in 15 fractions for 3 weeks.
RECRUITING
Shanghai Proton and Heavy Ion Center, Shanghai
Shanghai Proton and Heavy Ion Center
OTHER